TaperCommunityTaperCommunity
Propranolol (Inderal) Withdrawal: Rebound Tachycardia and Tapering Beta-Blockers

Propranolol (Inderal) Withdrawal: Rebound Tachycardia and Tapering Beta-Blockers

September 5, 2026
drug-specificpropranolol-withdrawal

Do not stop propranolol suddenly. Propranolol withdrawal rebound is a real, measurable physical event: your heart rate, blood pressure and adrenaline sensitivity can overshoot above where they were before you ever took the drug, usually within 2 to 7 days of the last dose. The safest approach is a gradual reduction rather than an abrupt stop, and for most people that means stepping down by roughly 10% of the current dose with 2 to 4 weeks between reductions. Propranolol (Inderal) is a non-selective beta-blocker prescribed for high blood pressure, angina, migraine prevention, tremor and performance anxiety, and every one of those groups can experience rebound. This guide covers what rebound is, how long it lasts, and how to come off without it.

What propranolol withdrawal rebound actually is

Propranolol withdrawal rebound is the temporary overshoot of heart rate, blood pressure and adrenaline-driven symptoms that happens when a beta-blocker is stopped faster than the body can readjust. It is not anxiety returning, and it is not "all in your head." It is a physiological correction that shows up on a pulse oximeter.

The classic evidence is a 1975 double-blind crossover trial published in the New England Journal of Medicine. Miller and colleagues abruptly stopped propranolol in 20 patients with angina, and within 2 weeks 10 of them developed new ischemic events, including 3 cases of intermediate coronary syndrome, one fatal myocardial infarction and one sudden death (Miller et al., 1975, indexed on PubMed). That single study is why the prescribing information for propranolol carries an explicit warning against abrupt discontinuation.

The risk is not limited to people with diagnosed heart disease. A population-based case-control study in JAMA found a transient fourfold increase in the relative risk of new coronary heart disease among hypertensive patients who had recently stopped filling their beta-blocker prescriptions, at a relative risk of 4.5 with a 95% confidence interval of 1.1 to 18.5 (Psaty et al., 1990, indexed on PubMed). Those patients had no prior cardiac history.

Most people who stop propranolol abruptly do not have a heart attack. What almost everyone gets is a stretch of racing pulse, pounding heartbeat, sweating and shakiness that feels worse than the symptom the drug was treating.

Bottom line: rebound is a documented cardiovascular phenomenon with real published mortality data behind it, not a nervous reaction to stopping a pill.

Why stopping propranolol suddenly causes rebound tachycardia

Rebound tachycardia happens because beta-blockade makes your body build more beta-adrenergic receptors, and those extra receptors are still there the moment the drug leaves.

Propranolol blocks beta-1 and beta-2 adrenergic receptors, the docking sites where adrenaline and noradrenaline land. That slows the heart, lowers the force of each contraction and blunts the physical signature of adrenaline: racing pulse, shaking hands, tight chest. Over weeks of daily dosing the body compensates by increasing the number and sensitivity of those receptors, a process called receptor upregulation (propranolol pharmacology, StatPearls on NCBI Bookshelf).

Propranolol has a short half-life of roughly 3 to 6 hours in the immediate-release form. When you stop, the blockade clears within a day, but the upregulated receptors take weeks to normalize. For that window your normal circulating adrenaline is landing on an oversized receptor population, so ordinary background stress produces an outsized cardiac response. That is the whole mechanism.

This explains why rebound is worst after months or years of daily propranolol and mildest in people who used it occasionally before a presentation or a flight. Intermittent use never builds the receptor surplus.

The evidence is not uniform. A 1986 analysis from the MILIS trial in Circulation found that abruptly stopping beta-blockade during an acute myocardial infarction did not increase infarct size or mortality, though those patients reported more recurrent chest pain in the first 24 hours (Croft et al., 1986, indexed on PubMed). Rebound is most dangerous in ambulatory, active people, not monitored hospital patients on bed rest.

Bottom line: propranolol withdrawal rebound is receptor upregulation meeting normal adrenaline with nothing in between, and the longer and higher the dosing, the bigger the overshoot.

The propranolol withdrawal timeline, day by day

Propranolol withdrawal symptoms usually begin 12 to 48 hours after the last dose, peak between days 2 and 7, and settle over 2 to 4 weeks as beta receptors return to baseline density.

| Time since last dose | What commonly happens | What it means | | | --- | | 6 to 12 hours | Drug level falls; resting pulse begins to climb | Normal clearance, not yet rebound | | 12 to 48 hours | Heart rate rises above pre-treatment baseline, palpitations start | Rebound beginning | | Days 2 to 7 | Peak rebound: tachycardia, raised blood pressure, tremor, sweating, chest tightness, insomnia, anxiety surges | The highest-risk window | | Weeks 2 to 4 | Symptoms fade in waves; heart rate trends back toward baseline | Receptors downregulating | | Beyond 4 weeks | Persistent symptoms are usually the original condition returning, not rebound | Time to reassess the underlying issue |

That last row matters. People often conclude at week 6 that they cannot live without propranolol, when what they are seeing is the untreated migraine pattern or hypertension the drug was covering.

Tapering shifts the whole timeline. Each small reduction produces a smaller version of the same curve, usually a few days of mild pulse elevation that settles before the next step: the same total change, broken into pieces your receptors keep up with.

Bottom line: expect the sharpest propranolol withdrawal rebound between days 2 and 7 after an abrupt stop, and expect a tapered reduction to compress that into a few mild days per step.

Propranolol withdrawal symptoms when you took Inderal for anxiety or migraine

The rebound symptoms are identical whether propranolol was prescribed for blood pressure, migraine or stage fright, because the receptor mechanism is the same. What differs is how the symptoms get interpreted.

If you took propranolol for anxiety, rebound tachycardia feels exactly like a panic attack. The pounding heart, shaking hands, chest tightness and flush of dread are the physical layer of panic, arriving without a trigger. Many people read this as proof their anxiety was severe all along and restart within a week. Timing is the distinguishing feature: rebound arrives 1 to 3 days after a cut and eases before the next one, while returning anxiety tracks life events.

If you took propranolol for migraine prevention, expect a cluster of headaches in the first 2 to 3 weeks off. Rebound raises heart rate and blood pressure and disrupts sleep, and all three are migraine triggers, so taper headaches are often withdrawal-driven rather than proof the prophylaxis was essential.

If you took propranolol for essential tremor, the tremor returns quickly and can briefly look worse than before treatment. This settles.

Other common effects across all groups: insomnia and vivid dreams, sweating, nausea, a jittery internal buzzing, and unusual reactivity to noise and stress. Some people are also taking benzodiazepines like Klonopin or Ativan for the same anxiety, and separating which drug is producing which symptom is far easier when only one is changing at a time.

Bottom line: propranolol rebound symptoms mimic the condition being treated, so date-stamp your symptoms against your dose changes rather than trusting how they feel.

How to taper off propranolol (Inderal) safely

The safest way off propranolol is a gradual, proportional reduction: cut roughly 10% of your current dose, hold 2 to 4 weeks until your pulse and symptoms settle, then cut 10% of the new lower dose. Reductions get smaller in absolute terms as the dose falls, which is the core of hyperbolic tapering.

Hyperbolic tapering is the practice of reducing by a percentage of the current dose rather than a fixed amount, because receptor occupancy falls off in a curve rather than a straight line. It is the same principle the Maudsley Deprescribing Guidelines and the Canadian Deprescribing Network apply to other drug classes. A fixed-milligram schedule front-loads the easy cuts and back-loads the hard ones, which is why so many people stall at the end.

Three practical rules make a propranolol taper hold together.

First, measure. A blood pressure cuff or a pulse reading twice a day, taken at the same times, turns an argument about feelings into data. If resting heart rate rises more than about 15 to 20 beats per minute over your pre-cut baseline and stays there, the step was too large. Log it in the taper journal so the pattern is visible across weeks.

Second, hold rather than reverse. Most rebound settles in days if you sit at the current dose, while going back up resets the receptor adaptation and costs more time than waiting.

Third, plan the whole descent before the first step. The taper planner maps the reduction curve, and the tapering plan worksheet covers what to track and what your stopping rules are.

Coronary artery disease, prior heart attack, arrhythmia or uncontrolled hypertension all mean a propranolol taper needs clinical monitoring, and the UK hypertension guideline is a useful reference to bring to that conversation (NICE guideline NG136). If your prescriber will not engage, our deprescriber directory lists clinicians who taper for a living.

Bottom line: percentage-based cuts, a pulse log, and holding instead of reversing will get most people off propranolol without a rebound crisis.

"I have taken propranolol for public speaking for 3 years and my doctor says just stop. Is that safe?"

For daily use over 3 years, no, and the advice is worth pushing back on. Daily dosing for years is exactly the pattern that builds maximal beta-receptor upregulation, so an abrupt stop produces the fullest version of rebound tachycardia. Ask for a taper.

The advice gets given casually because propranolol carries no addiction stigma and no controlled-substance paperwork, so it is filed mentally as harmless. The prescribing information disagrees. The FDA-approved label for propranolol, available through DailyMed at the National Library of Medicine, warns explicitly against abrupt cessation and instructs that dosage be reduced gradually over a period of weeks.

Occasional use is genuinely different. If you take propranolol only before a specific performance, a few times a month, there is no sustained blockade to rebound from and you can stop without a taper.

One more thing is worth naming. Propranolol used for performance anxiety blunts the physical feedback loop of fear, so coming off means meeting a bodily sensation you have not felt in years, on top of actual rebound. Building a non-drug approach before you start reducing, rather than during, makes the difference.

Bottom line: years of daily propranolol needs a taper regardless of what the drug is prescribed for, while genuinely occasional use does not.

When propranolol rebound needs urgent medical attention

Most propranolol withdrawal rebound is uncomfortable and self-limiting. A specific subset is not, and knowing the difference prevents both unnecessary panic and dangerous delay.

Seek emergency care for chest pain or pressure, especially pain radiating to the arm, jaw or back, and especially with known coronary artery disease. The Miller trial documented myocardial infarction and sudden death within 2 weeks of abrupt withdrawal in angina patients, so chest pain during propranolol withdrawal is never a symptom to ride out at home. The same applies to a resting heart rate persistently above 120, fainting or near-fainting, severe shortness of breath, or a blood pressure reading far above your usual range that does not come down over several hours.

Contact your prescriber the same week, without an emergency room, for a resting pulse steadily 20 to 30 beats above baseline for more than a few days, palpitations that wake you, or blood pressure climbing past pre-treatment levels.

None of that means a taper is unsafe. It means propranolol acts directly on the cardiovascular system, so the monitoring threshold differs from psychiatric drug tapers. Patient-led resources like Surviving Antidepressants and reporting projects like RxISK collect withdrawal experiences clinical trials never captured, and Mad in America covers the gap between prescribing practice and withdrawal evidence.

Bottom line: chest pain, fainting or a resting pulse over 120 during propranolol withdrawal is an emergency, while an elevated but stable pulse is expected and manageable.

Frequently asked questions

How long does propranolol withdrawal last?

Acute rebound peaks between days 2 and 7 after the last dose and largely resolves within 2 to 4 weeks as beta-adrenergic receptors return to normal density. A taper replaces one large episode with a series of milder few-day ones. Symptoms persisting past 6 weeks are usually the original condition returning rather than withdrawal.

Can I stop propranolol cold turkey if I only take 10mg a day?

Low doses still cause receptor upregulation, so daily 10mg use for months can still rebound. It is generally milder than at 80mg or higher, but milder is not absent. Taper if you have any cardiac history, a hypertension diagnosis, or more than about 6 weeks of daily use.

Does propranolol withdrawal cause anxiety, or is my anxiety just coming back?

Both happen, and timing separates them. Rebound anxiety appears 1 to 3 days after a dose reduction, is dominated by physical symptoms like racing heart and tremor, and fades within 2 weeks with no change in circumstances. Returning anxiety tracks life events and carries more cognitive worry than raw physical arousal.

I stopped propranolol 4 days ago and my heart is racing at 110. Should I restart it?

A resting pulse of 110 on day 4 is textbook rebound and typically settles over the following 1 to 2 weeks. With no chest pain, no fainting and no shortness of breath, most people can wait it out while tracking pulse twice a day. Restarting at the previous dose and then tapering properly is reasonable and not a failure. Get urgent care for chest pain, fainting or a sustained pulse above 120.

Is propranolol withdrawal dangerous for someone with no heart problems?

The serious cardiac events in the literature cluster in people with existing coronary disease, but the JAMA analysis by Psaty and colleagues found a fourfold transient risk increase in hypertensive patients with no prior cardiac history. Most healthy people under 40 come through an abrupt stop with unpleasant symptoms and nothing worse, though a taper makes it far more comfortable.

Coming off propranolol without the rebound

Propranolol withdrawal rebound is predictable, which makes it manageable. The drug leaves within a day while the receptor adaptation takes weeks, and a taper closes that gap by making each reduction small enough that your physiology keeps pace. Percentage-based cuts, a twice-daily pulse log, holds instead of reversals, and clinical monitoring if you have any cardiac history will get most people to zero without a crisis.

taper.community is a free peer forum and resource library for people reducing or stopping prescribed medication, built on hyperbolic tapering and slow proportional dose reductions. Reading the propranolol drug profile is a good starting point, and the community forums are where people compare notes on what an actual week-by-week beta-blocker taper looked like for them.

If your prescriber told you to just stop and that did not go well, you are not the exception. You ran into a documented pharmacological effect that the label itself warns about.

This article is for information only and is not medical advice. Propranolol acts directly on the heart and circulation, and stopping it abruptly carries real cardiovascular risk. Do not change your dose without discussing it with a prescriber, and seek emergency care for chest pain, fainting or severe shortness of breath.


0 Comments

By posting, you give your explicit consent for us to process the information you share, including health data, which the GDPR treats as a special category of personal data. Learn how we handle it.